If you're a fan of the inner workings of Hollywood, then check out my podcast, The Town, on the Ringer Podcast Network.

My name's Matt Bellany. I'm founding partner at Puck and the writer of the What I'm Hearing newsletter.

And with my show, The Town, I bring you the inside conversation about money and power in Hollywood.

Every week, we've got three short episodes featuring real Hollywood insiders to tell you what people in town are actually talking about.

We'll cover everything from why your favorite show is canceled overnight, which streamer is on the brink of

collapse, and which executives on the hot seat. Disney, Netflix, who's up, down, and who'll never

eat lunch in this town again? Follow the town on Spotify or wherever you get your podcast.

Hi, everybody, Derek here.

In December, my wife and I welcomed our second baby girl into the world.

I'm going to be taking some time off, but we wanted to keep the pod going through the holidays.

So we're going to be re-airing some of our favorite episodes from the last 12 months, a kind of

best of compendium. And this list includes interviews that really stuck with me and others that

really stuck with you and you had lots of feedback and thoughts on, including this one.

I'll be back in the new year with fresh content, but until then, happy holidays and happy

new year.

Today, would I consider the most interesting question in all of medical science?

How are GLP1 drugs so good at everything?

And if indeed they are good at everything, should we all be on them?

Several years ago, scientists took a close look at GLP1 drugs, such as Ozempic, and learned that they were pretty good at helping people lose weight. In the last

few years, they've taken an even closer look and learned that these drugs are good at just about

everything else. GLP1s, technically known as glucagon-like peptide-1 receptor agonists, seem to curb alcohol,

cocaine, and tobacco use among addicts.

...